Nombre del producto:(4-Bromo-3-methylisoxazol-5-yl)methyl acetate

IUPAC Name:(4-bromo-3-methyl-1,2-oxazol-5-yl)methyl acetate

CAS:1380089-33-7
Fórmula molecular:C7H8BrNO3
Pureza:97%
Número de catálogo:CM249144
Peso molecular:234.05

Unidad de embalaje Stock disponible Precio($) Cantidad
CM249144-1g in stock ƋDz
CM249144-5g in stock ǕȦȦ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :1380089-33-7
Fórmula molecular:C7H8BrNO3
Punto de fusión:-
Código de sonrisas:CC(OCC1=C(Br)C(C)=NO1)=O
Densidad:
Número de catálogo:CM249144
Peso molecular:234.05
Punto de ebullición:
Nº Mdl:MFCD24387374
Almacenamiento:Store at room temperature.

Category Infos

Isoxazoles
Isoxazole is a liquid heterocyclic compound C3H3NO isomeric with oxazole and having a penetrating odor like that of pyridine. Isoxazoles belong to an important class of five-membered aromatic heterocycles containing two electronegative heteroatoms, nitrogen and oxygen, in a 1,2-relationship and three regular sp2 carbon atoms. These molecules are found to be key components in various synthetic products in daily use and also present as a pharmacophore essential for biological activity in many drugs and bioactive natural products. In addition, isoxazoles have demonstrated their ability to exhibit hydrogen bond donor/acceptor interactions with a variety of enzymes and receptors.

Column Infos

Pelabresib
MorphoSys’ phase 3 study of Pelabresib in myelofibrosis demonstrates statistically significant improvement in spleen volume reduction and strong positive trend in symptom reduction.
Pelabresib (CPI-0610) is an investigational selective small molecule designed to promote anti-tumor activity by inhibiting the function of bromodomain and extra-terminal domain (BET) proteins to decrease the expression of abnormally expressed genes in cancer. MorphoSys intends to submit for approval in the U.S. and Europe in mid-2024.

Related Products